TOP > INVESTOR RELATIONS > Disclosure policy
As a true “ Global Pharmaceutical Innovator ”, aiming to win a high level of social trust, DAIICHI SANKYO makes great efforts to thoroughly disclose information so that all stakeholders, including shareholders and investors both in Japan and overseas, are aware of the current status of the group and are able to evaluate it.
■ Information Disclosure Policy
DAIICHI SANKYO discloses information based on transparency, impartiality and continuity, and in compliance with the Securities and Exchange Act and the Stock Exchange’s timely disclosure rules. In addition, we make efforts to disclose in a timely and proactive manner what we consider to be informative in aiding understanding of our group.
■ Information Disclosure Method
DAIICHI SANKYO makes prompt disclosure through such channels as the Timely Disclosure Network (TDnet), News releases, news conferences and briefing sessions. We also endeavor to improve our system to facilitate access to all kinds of disclosed information by such methods as posting it on our website.
■ In-Company Information Disclosure System
DAIICHI SANKYO is endeavoring to upgrade and enrich its in-company system for the rapid, accurate and impartial disclosure of information in an appropriate manner.
■ Disclosure of Future Prospects
In addition to submitting earnings forecasts to the Tokyo Stock Exchange, DAIICHI SANKYO occasionally provides investors and stock analysts with prospect-related guidance so that they can make their own forecasts of its results. Any statements in messages, lectures, or question-and-answer sessions that are not historical facts should be considered as forward-looking statements made on the basis of certain assumptions and judgments in light of the information currently available to us. They may, therefore, include a certain degree of risk and indeterminate factors.
■ Quiet Period
To prevent leaks of information and to safeguard impartiality, DAIICHI SANKYO has instituted, as a general rule, a quiet period which begins three weeks preceding the announcement of half-year or full-year financial results, and two weeks preceding the announcement of first or third quarter financial results are announced publicly.
During this period, we will refrain from making any comments externally or responding to any questions regarding the business results. However, if during this quiet period any matter should emerge that falls under timely disclosure rules, we will comply with the rules and make disclosure accordingly.
